Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nicotine and the renin-angiotensin system
Joshua M. Oakes, Robert Fuchs, Jason D. Gardner, et al.
AJP Regulatory Integrative and Comparative Physiology (2018) Vol. 315, Iss. 5, pp. R895-R906
Open Access | Times Cited: 321

Showing 1-25 of 321 citing articles:

Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study
Simon de Lusignan, Jienchi Dorward, Ana Correa, et al.
The Lancet Infectious Diseases (2020) Vol. 20, Iss. 9, pp. 1034-1042
Open Access | Times Cited: 645
<p>How Western Diet And Lifestyle Drive The Pandemic Of Obesity And Civilization Diseases</p>
W Köpp
Diabetes Metabolic Syndrome and Obesity (2019) Vol. Volume 12, pp. 2221-2236
Open Access | Times Cited: 546
Risk factors for Covid-19 severity and fatality: a structured literature review
Dominik Wolff, Sarah Nee, Natalie Sandy Hickey, et al.
Infection (2020) Vol. 49, Iss. 1, pp. 15-28
Open Access | Times Cited: 490
Clinical Characteristics of Covid-19 in China
Joon Young Song, Jin Chin Hee, Joo Hee Kim, et al.
New England Journal of Medicine (2020) Vol. 382, Iss. 19, pp. 1859-1862
Closed Access | Times Cited: 475
Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)
Giuseppe Lippi, Brandon Michael Henry
European Journal of Internal Medicine (2020) Vol. 75, pp. 107-108
Open Access | Times Cited: 418
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
Franck Touret, Magali Gilles, Karine Barral, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 414
Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract
Joan C. Smith, Erin L. Sausville, Vishruth Girish, et al.
Developmental Cell (2020) Vol. 53, Iss. 5, pp. 514-529.e3
Open Access | Times Cited: 397
Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor
Yanwei Li, Wei Zhou, Yang Li, et al.
Pharmacological Research (2020) Vol. 157, pp. 104833-104833
Open Access | Times Cited: 375
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta‐analyses (version 7)
David Simons, Lion Shahab, Jamie Brown, et al.
Addiction (2020) Vol. 116, Iss. 6, pp. 1319-1368
Open Access | Times Cited: 361
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?
Konstantinos Farsalinos, Anastasia Barbouni, Raymond Niaura
Internal and Emergency Medicine (2020) Vol. 15, Iss. 5, pp. 845-852
Open Access | Times Cited: 303
A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications
Jean‐Pierre Changeux, Zahir Amoura, F.A. Rey, et al.
Comptes Rendus Biologies (2020) Vol. 343, Iss. 1, pp. 33-39
Open Access | Times Cited: 294
Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
Konstantinos Farsalinos, Raymond Niaura, Jacques Le Houezec, et al.
Toxicology Reports (2020) Vol. 7, pp. 658-663
Open Access | Times Cited: 252
Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis
Tu‐Hsuan Chang, Jhong-Lin Wu, Luan‐Yin Chang
Journal of the Formosan Medical Association (2020) Vol. 119, Iss. 5, pp. 982-989
Open Access | Times Cited: 246
ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
Donato Zipeto, Julys da Fonseca Palmeira, Gustavo Adolfo Arganãraz, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 244
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply
Konstantinos Farsalinos, Anastasia Barbouni, Raymond Niaura
Internal and Emergency Medicine (2020) Vol. 16, Iss. 1, pp. 235-236
Open Access | Times Cited: 219
Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity
Wakako Sakaguchi, Nobuhisa Kubota, Tomoko Shimizu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6000-6000
Open Access | Times Cited: 189
Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking
Ayşe Başak Engin, Doruk Engin, Atilla Engin
Environmental Toxicology and Pharmacology (2020) Vol. 78, pp. 103411-103411
Open Access | Times Cited: 183
Cluster of COVID-19 in northern France: A retrospective closed cohort study
Arnaud Fontanet, Laura Tondeur, Yoann Madec, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 179
COVID-19 and smoking: is nicotine the hidden link?
Patrizia Russo, Stefano Bonassi, Robertina Giacconi, et al.
European Respiratory Journal (2020) Vol. 55, Iss. 6, pp. 2001116-2001116
Open Access | Times Cited: 177
Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis
Konstantinos Farsalinos, Anastasia Barbouni, Konstantinos Poulas, et al.
Therapeutic Advances in Chronic Disease (2020) Vol. 11
Open Access | Times Cited: 172
Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients
Lori B. Daniels, Amy M. Sitapati, Jing Zhang, et al.
The American Journal of Cardiology (2020) Vol. 136, pp. 149-155
Open Access | Times Cited: 170
Is there a smoker’s paradox in COVID-19?
Muhammad Usman, Tariq Jamal Siddiqi, Muhammad Shahzeb Khan, et al.
BMJ evidence-based medicine (2020) Vol. 26, Iss. 6, pp. 279-284
Open Access | Times Cited: 146
Impact of Tobacco Smoking on the Risk of COVID-19: A Large Scale Retrospective Cohort Study
N. Paleiron, Aurélie Mayet, Vanessa Marbac, et al.
Nicotine & Tobacco Research (2021) Vol. 23, Iss. 8, pp. 1398-1404
Open Access | Times Cited: 125
Smoking patterns and outcomes of severe sars-CoV-2 infection: a retrospective cohort study
Branko Beronja, Aleksandra Karan, Biljana Lukić, et al.
Monaldi Archives for Chest Disease (2025)
Open Access | Times Cited: 2
Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk
Nadine Kabbani, John Olds
Molecular Pharmacology (2020) Vol. 97, Iss. 5, pp. 351-353
Open Access | Times Cited: 134
Page 1 - Next Page

Scroll to top